Cargando…
442 Repurposing FDA-approved PI3K/Akt Inhibitors to Improve Anti-Cancer Drug Brain Uptake in Glioblastoma Resection Models
OBJECTIVES/GOALS: We have shown that glioblastoma upregulates blood-brain barrier drug efflux transporters via a mechanism that likely involves TNFα and PI3K/Akt. Our goal is to repurpose FDA-approved PI3K/Akt inhibitors to increase anticancer drug brain concentrations, which holds the potential fo...
Autores principales: | Rodgers, Louis, Tega, Yuma, Schulz, Julia A., Hartz, Anika M.S., Bauer, Bjoern |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209188/ http://dx.doi.org/10.1017/cts.2022.258 |
Ejemplares similares
-
384 Motives for kratom self-medication: contents of public comments solicited by the FDA
por: Tobacyk, Julia, et al.
Publicado: (2022) -
241 Utilizing real-world evidence to increase efficiency of randomized controlled trials with application to repurposed therapeutics for COVID-19
por: Haine, Lillian M F, et al.
Publicado: (2022) -
426 Long non-coding RNA WNT5A-AS1 shows sex-dimorphic differences in survival for males with glioblastoma
por: Miller, Aunay, et al.
Publicado: (2022) -
323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
por: Reed, Megan R., et al.
Publicado: (2022) -
418 Activation of the Glucagon-Like Peptide-1 Pathway in Obese Pre-Diabetic Individuals Improves Endothelial Function Independently of Weight Loss
por: Mashayekhi, Mona, et al.
Publicado: (2022)